LTIMindree: The company will replace HDFC Ltd. in Nifty 50 after mega HDFC merger. It will move from Nifty Next 50 to Nifty 50. The replacement will come into effect on July 13. The replacement will also be applicable to Nifty50 Equal Weight index.
Samvardhana Motherson International: The company, via unit SMRP B.V., will buy 81% stake in Yachiyo's 4W business, housed under Japan's Yachiyo Industry Co. Ltd. The stake is valued at JPY 22.9 billion (Rs 1,301 crore) for 100% stake. Honda Motor will own 19%, making it 81:19 joint venture.
Jindal Steel & Power: The company will replace HDFC in Nifty 100.
Mankind Pharma: The company will replace HDFC in Nifty 500, Nifty 200, Nifty Large Midcap 250 and Nifty Total Market
LIC Housing Finance: The company will replace HDFC in Nifty Financial Services.
Phoenix Mills: The company will replace HDFC in Nifty Housing.
Brigade Enterprises: The company will replace HDFC in Nifty Core Housing
Ambuja Cements: The company will replace HDFC in Nifty High Beta 50.
State Bank of India: The lender has approved to acquired entire stake held by unit SBI Capital Markets in SBICAP Ventures for a cash consideration of Rs 708.07 crore.
Bandhan Bank: Bandhan Bank Chief Financial Officer Sunil Samdani has resigned, with effect from Sept. 30, and decided to explore professional opportunities outside the bank. The bank is in the process of identifying a suitable candidate for the office of CFO.
Syngene International, Strides Pharma: Stelis Biopharma, the biologics arm of Strides, has signed a binding term sheet with Syngene International Ltd. to divest its Unit 3 multi-modal facility in Bengaluru for a gross consideration of Rs 702 crore. Syngene further invest up to Rs 100 crore to repurpose and revalidate the facility. The site will have a manufacturing capacity of 20,000 litres of ins
Bharat Heavy Electricals: The company has extended its gas turbines technology agreement with General Electric Technology GmbH Switzerland. Under this extension, BHEL has gained access and enhanced rights for existing, uprated and new gas turbine models.
Aurobindo Pharma: Company’s breast cancer biosimilar product, BP02 Trastuzumab, developed by unit Curateq Biologics has met its primary endpoint in Phase III clinical trials and has shown equivalent efficacy to Herceptin biosimilar.
Bata India: The company has approved the appointment of Anil Ramesh Somani as chief financial officer for a period of five years from April 25, 2023.
Manali Petrochemicals: The company has inked two captive power agreements with two separate units of First Energy for procurement of wind power and solar power for a total consideration of Rs 356.4 lakh.
HPCL Rajasthan Refinery Limited executes a loan agreement under a consortium arrangement for Rs 48,625 crore
Som Distilleries to consider raising funds via equity warrants on July 8
RBLBank Q1 Biz Update: Total deposits up 8% at Rs 85,638 cr Vs Rs 84,887 cr (QoQ)
AU Small Fin Bank Q1: Total deposits up 27% at Rs 69,315 cr Vs Rs 54,631 cr (YoY)
Hewlett Packard Enterprise announces its plans to begin manufacturing high-volume servers in India
Lemon Tree signs licence pact For A 48-room Property In Udaipur, Rajasthan
Macrotech Developers Q1 Biz Update: Pre-sales up 17% YoY & down 11% QoQ, at Rs 3,350 cr
Collections down 8% YoY & down 18% QoQ, at Rs 2,400 cr
Net debt down 18.1% at Rs 7,260 cr Vs Rs 8,860 cr (YoY)
SuzlonEnergy to consider fund raising on July 7 by way of one or more or combination of permissible methods
Lupin gets US FDA nod for its ANDA Dolutegravir tabs for oral suspension & to market generic equivalent of Tivicay PD tabs for oral suspension
IOC to consider raising funds via RightsIssue on July 7
No comments:
Post a Comment